Your search for non small cell lung cancer returned 129 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

News remove
Older than 2 years remove
Home remove

Your search for non small cell lung cancer returned 129 results

Sort Results:

Relevant Recent
News

Durvalumab Extends Survival vs Placebo in Stage 3 Non-Small Cell Lung CA

Overall survival was significantly prolonged with durvalumab versus placebo (stratified hazard ratio [HR] for death, 0.68; P=.0025). For progression-free survival, the median duration was 17.2 months in the durvalumab group and 5.6 months in the placebo group.
ACR/ARHP 2018 Annual Meeting

Biologic DMARD Treatment Linked to Weight Gain in Inflammatory Arthritis

Small but significant increases in weight (0.02lb) and BMI (0.006 lbl P<.001 for both) were observed over time. Moreover, a negative association between DAS28 and increased weight (-0.56) as well as BMI (-0.08; P<.001 for both) was reported, implying that an increase in weight was linked to lower disease activity.